Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
Key Characteristics MOLECULAR PROFILE Formula: C 14 H 22 CuN 6 O 4 Weight: 401.9 g/mol CAS: 89030-95-5 Structure: Gly-His-Lys (with bound copper) PHYSICAL PROPERTIES Form: Blue crystalline powder (the blue color comes from the copper) Solubility: Highly water-soluble Natural Occurrence: Found in human plasma, saliva, and urine Storage: Keep refrigerated 3646 F (28 C), protect from light
Fico, A., Maina, F
Table 11: Results at Week 26 in a Trial Comparing TRESIBA to Insulin Glargine U -100 in Adult Patients with Type 2 Diabetes Mellitus on OAD(s)* Study G TRESIBA Administered at the Same Time Each Day or Any Time Each Day as an Add on to One and up to Three of the Following Oral Agents Metformin, Sulfonylurea or Glinides or Pioglitazone in Adult Patients The efficacy of TRESIBA was evaluated in a 26 week randomized, open label, multicenter trial in 687 patients with type 2 diabetes mellitus inadequately controlled on basal insulin alone, oral antidiabetic agents (OADs) alone or both basal insulin and OAD
Clinical Status Human RCT | Observational | Animal | In vitro Clinically evaluated and approved in certain jurisdictions for specific photoprotection indications
This article compares the two products across their composition, mechanisms, and research applications
US$ 23.32
US$ 22.68
US$ 26.43
US$ 25.01
